EBOS Group Ltd
NZX:EBO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
31.85
38.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches NZD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
EBOS Group Ltd
Free Cash Flow
EBOS Group Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
EBOS Group Ltd
NZX:EBO
|
Free Cash Flow
AU$229.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
22%
|
CAGR 10-Years
12%
|
||
Me Today Ltd
NZX:MEE
|
Free Cash Flow
-NZ$3.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
EBOS Group Ltd
Glance View
EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is also an animal care products marketer and distributor. Its segments include Healthcare, Animal care and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare, wholesale activities and logistics. The Animal care segment incorporates the sale of animal care products in a range of sectors, own brands, retail and wholesale activities. Its businesses include Community Pharmacy, Institutional Healthcare, Contract Logistics and Animal Care. Community Pharmacy includes Symbion, Endeavour Consumer Health, ProPharma, DoseAid and Intellipharm. Institutional Healthcare includes EBOS Healthcare, Onelink, Clinect and Zest. Contract Logistics comprises Healthcare Logistics, Symbion Contract Logistics and Symbion Clinical Trials. Animal Care includes Masterpet, Lyppard, Animates and Vitapet.
See Also
What is EBOS Group Ltd's Free Cash Flow?
Free Cash Flow
229.4m
AUD
Based on the financial report for Jun 30, 2024, EBOS Group Ltd's Free Cash Flow amounts to 229.4m AUD.
What is EBOS Group Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
12%
Over the last year, the Free Cash Flow growth was -22%. The average annual Free Cash Flow growth rates for EBOS Group Ltd have been 2% over the past three years , 22% over the past five years , and 12% over the past ten years .